ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Join SI Premium – FREE
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ericsson (ERIC) Tops Q2 EPS by 3c
- Guardian Metal Resources PLC Announces Non-Core Portfolio Exploration Results
- Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
